IP Library Granted Patent US 12,589,067
Granted Patent B2
US 12,589,067 · App. 18/329,003 · Granted Mar 31, 2026

Composition and methods for activating cellular signaling genes in innate inflammatory pathways

Inventors: Elisa Diane Barnes (Draper, UT); Christina Beer (Salt Lake City, UT)
Assignee: LIFEVANTAGE CORPORATION
A61K8/9794A61K8/65A61K8/9789A61K36/21A61K36/28A61K36/68A61K36/81A61K36/82A61K36/9066A61K38/39A61K45/06A61Q19/08A61K2800/522A61K2800/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,589,067
App. No.
18/329,003
Granted
Mar 31, 2026
Kind
B2
Abstract

Nutritional supplements and compositions for activating cellular signaling genes in innate inflammatory pathways are described in this application. In particular, this application describes a composition containing a solid portion comprising Bacopa monnieri extract having a least 20 percent bacosides, Silybum marianum (milk thistle) extract having 70 percent to about 80 percent silymarin, milk thistle extract, Withania somnifera (ashwagandha) extract, Camellia sinensis (green tea) extract containing at least 40 percent epigallocatechin gallate and about 98 percent polyphenols; and Curcuma longa (turmeric) extract containing at least about 95 percent curcumin. The compositions also comprise a liquid portion comprising fish collagen peptides comprising about 90 percent protein and Formosa ruby quinoa water extract containing about 10 wt % extract and about 90 wt % water. These compositions improved the skin and impacted key regulatory genes associated with several important cellular pathways. Other embodiments are also described.

Claims (57)

1 . A composition, comprising:

about 162.5 mg to about 2700 mg of a first portion, comprising:

from about 150 mg to about 500 mg Bacopa monnieri extract having a least 20 weight percent bacosides;

from about 225 mg to about 500 mg Silybum marianum extract having 70 weight percent to about 80 weight percent silymarin;

from about 150 mg to about 500 mg Withania somnifera extract;

from about 75 mg to about 500 mg Camellia sinensis extract comprised of at least 40 weight percent epigallocatechin gallate and about 98% polyphenols; and

from about 75 mg to about 500 mg Curcuma longa extract comprised of at least about 95 weight percent curcumin; and

about 12.5 ml to about 100 ml of a second portion, comprising:

from about 500 mg to about 15,000 mg fish collagen peptides comprising about 90 weight percent protein; and

from about 500 mg to about 15,000 mg formosa ruby quinoa mixture containing about 10 wt % extract and about 90 wt % water.

2 . The composition of claim 1 , wherein the first portion is a solid and the second portion is a liquid.

3 . The composition of claim 1 , wherein the composition contains from about 325 mg to about 1350 mg of the first portion.

4 . The composition of claim 1 , wherein the composition contains from about 25 ml to about 75 ml of the second portion.

5 . The composition of claim 1 , wherein the composition contains about 675 mg of the first portion.

6 . The composition of claim 1 , wherein the composition contains about 50 ml of the second portion.

7 . The composition of claim 1 , wherein the second portion contains from about 1000 mg to about 10,000 mg fish collagen peptides.

8 . The composition of claim 1 , wherein the second portion contains from about 1000 mg to about 10,000 mg formosa ruby quinoa extract.

9 . The composition of claim 1 , wherein the second portion contains from about 1000 mg to about 10,000 mg of a lycopene-containing food source.

10 . The composition of claim 1 , wherein the second portion contains from about 50 mg to about 1000 mg of an herbal combination of young ponkan fruit and blueberry powder.

11 . A nutritional supplement, comprising:

about 325 mg to about 1350 mg of a solid portion, comprising:

from about 150 mg to about 500 mg Bacopa monnieri extract having a least 20 weight percent bacosides;

from about 225 mg to about 500 mg Silybum marianum extract having 70 weight percent to about 80 weight percent silymarin;

from about 150 mg to about 500 mg Withania somnifera extract;

from about 75 mg to about 500 mg Camellia sinensis extract, wherein said green tea extract is comprised of at least 40 weight percent epigallocatechin gallate and about 98% polyphenols; and

from about 75 mg to about 500 mg Curcuma longa extract, wherein said turmeric extract is comprised of at least about 95 weight percent curcumin; and

about 25 ml to about 75 ml of a liquid portion, comprising:

from about 500 mg to about 15,000 mg fish collagen peptides comprising about 90 weight percent protein; and

from about 500 mg to about 15,000 mg formosa ruby quinoa mixture containing about 10 wt % extract and about 90 wt % water.

12 . The composition of claim 11 , wherein the composition contains about 675 mg of the first portion.

13 . The composition of claim 11 , wherein the composition contains about 50 ml of the second portion.

14 . The composition of claim 11 , wherein the second portion contains from about 1000 mg to about 10,000 mg fish collagen peptides.

15 . The composition of claim 11 , wherein the second portion contains from about 1000 mg to about 10,000 mg formosa ruby quinoa extract.

16 . The composition of claim 11 , wherein the liquid portion further comprises about 1000 mg to about 10,000 mg of a lycopene-containing food source.

17 . The composition of claim 11 , wherein the liquid portion further comprises about 50 mg to about 1000 mg of an herbal combination of young ponkan fruit and blueberry powder.

18 . A method of improving the skin condition of an individual comprising administering to that individual a composition comprising:

about 675 mg of a solid portion, comprising:

about 150 mg Bacopa monnieri extract having a least 20 weight percent bacosides;

about 225 mg Silybum marianum extract having 70 weight percent to about 80 weight percent silymarin;

about 150 mg Withania somnifera extract;

about 75 mg Camellia sinensis extract, wherein said green tea extract is comprised of at least 40 weight percent epigallocatechin gallate and about 98% polyphenols; and

about 75 mg Curcuma longa extract, wherein said turmeric extract is comprised of at least about 95 weight percent curcumin; and

about 50 ml of a liquid portion, comprising:

about 5000 mg fish collagen peptides comprising about 90 weight percent protein; and

about 5000 mg formosa ruby quinoa mixture containing about 10 wt % extract and about 90 wt % water.

19 . The method of claim 18 , wherein the composition is administered to the individual for at least 30 days or more.

20 . A method of activating cellular signaling genes in innate inflammatory pathways, comprising administering to an individual a composition comprising:

about 675 mg of a solid portion, comprising:

about 150 mg Bacopa monnieri extract having a least 20 weight percent bacosides;

about 225 mg Silybum marianum extract having 70 weight percent to about 80 weight percent silymarin;

about 150 mg Withania somnifera extract;

about 75 mg Camellia sinensis extract, wherein said green tea extract is comprised of at least 40 weight percent epigallocatechin gallate and about 98% polyphenols; and

about 75 mg Curcuma longa extract, wherein said turmeric extract is comprised of at least about 95 weight percent curcumin; and

about 50 ml of a liquid portion, comprising:

about 5000 mg fish collagen peptides comprising about 90 weight percent protein; and

about 5000 mg formosa ruby quinoa mixture containing about 10 wt % extract and about 90 wt % water.

21 . The method of claim 20 , wherein the composition is administered to the individual for at least 30 days or more.

Assignments (2)
SECURITY INTEREST Recorded Apr 12, 2024
From: LIFEVANTAGE CORPORATION
To: BANK OF AMERICA, N.A.
Reel/Frame 067093/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2023
From: BARNES, ELISA DIANE; BEER, CHRISTINA
To: LIFEVANTAGE CORPORATION
Reel/Frame 063933/0465 →
Continuity (1)
Related Publication 20240398693A1 · Dec 5, 2024
References Cited (14)
US 8435574B2 · Myhill et al. · 2013 [cited by applicant]
US 11484563B2 · Dixon et al. · 2022 [cited by examiner]
US 20050226942A1 · Myhill et al. · 2005 [cited by applicant]
US 20100136144A1 · Msika · 2010 [cited by applicant]
US 20150265527A1 · Su et al. · 2015 [cited by applicant]
US 20160128367A1 · Huntsman · 2016 [cited by applicant]
US 20170065654A1 · Rubin · 2017 [cited by applicant]
US 20210137826A1 · Lin et al. · 2021 [cited by applicant]
International Search Report and Written Opinion for PCT/US2024/032525, mailed Sep. 3, 2024, 11 pages. [cited by applicant]
Lifevantage Corporation. “Liquid Collagen” WEB. Downloaded from the URL: Https://cdn.lifevantage.com/wp-content/uploads/sites/2/2023/02/23153553/230216_02-AU-NZ-TS-Liquid-Collagen-Product-Info_Sheet.pdf. Mar. 14, 2023; … [cited by applicant]
Pawar, et al. “Development of Regulatory Mechanism of Food Product Accessible Antioxidants: Lycopene and Curcumin” International Journal of Engineering and Advanced Technology vol. 9 Issue-1S3. Dec. 2019; <pp. 64-65, ta… [cited by applicant]
Chang H. C, Lin Y. K, Lin Y. H, Lin Y. H, Hu W. C, Chiang C. F. Hydrolyzed Collagen Combined with Djulis and Green Caviar Improve Skin Condition: A Randomized, Placebo-Controlled Trial. Curr Res Nutr Food Sci 2021; 9(2)… [cited by applicant]
LifeVantage Corporation. (2022) Efficacy Evaluation of Red Quinoa. [cited by applicant]
Lin, P, Alexander, RA, Liang, C-H, et al. Collagen formula with Djulis for improvement of skin hydration, brightness, texture, crow's feet, and collagen content: A double-blind, randomized, placebo-controlled trial. J C… [cited by applicant]